Hypothesis: A possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis

Journal of Neuroscience Research

Volumn 45, Issue 4, 1996, Pages 340-348

  Bebo Jr , B F ^a,e   Yong, T ^b   Orr, E L ^d   Linthicum, D S ^b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH TEXAS   (United States)

^e NONE   (United States)

Author keywords

encephalomyelitis; mast cells; microcirculation; vasoactive

Indexed keywords

HISTAMINE; KALLIKREIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; HELPER CELL; HYPOTHESIS; INFLAMMATORY CELL; MAST CELL; MEDIATOR RELEASE; MICROCIRCULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION MEDIATORS; MAST CELLS;

EID: 9544237128     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960815)45:4<340::AID-JNR3>3.0.CO;2-9     Document Type: Article

References (50)

1. Askenase PW (1983): Delayed-type hypersensitivity: Activation of mast cells by antigen-specific T cell factors initiates the cascade of cellular interactions. Immunol Today 4:259-264.
2. Askenase P, Rosenstein R, Ptak W (1983): T cells produce an antigen-binding factor with in vivo activity analogous to IgE antibody. J Exp Med 157:862-873.
3. Askenase S, Bursztajn S, Gershon M, Gershon R (1980): T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med 152:1358-1374.
4. Babington R, Wedeking P (1971): The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE). J Pharmacol Exp Ther 177:455-460.
5. Bebo BF, Lee CH, Orr EL, Linthicum DS (1996): Mast-cell-derived histamine and tumor necrosis factor: Differences between SJL/J and BALB/c inbred strains of mice. Immunol Cell Biol 74:225-230.
6. Ben-Nun A, Cohen I (1982): Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: Process of selection of lines and characterization of the cells. J Immunol 129:303-308.
7. Bernard CCA, Mandel TE, Mackay IR (1992): Experimental models of human autoimmune diseases: Overview and prototypes. In Rose NR, Mackay IR (eds): "The Autoimmune Diseases II." San Diego: Academic Press, pp 47-106.
8. Bevilacqua MP, Nelson RM (1993): Selectins. J Clin Invest 91:379-387.
9. Bevilacqua MP, Pober JS, Mendrick DI, Cotran RS, Gimbrone MA (1987): Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84:9238.
10. Brosnan C, Lyman W, Tansey F, Carter T (1985): Quantitation of mast cells in experimental allergic neuritis. J Neuropathol Exp Neural 44:196-203.
11. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SP, Dvorak AM, Galli SJ, Dorf ME (1989): Interleukin 3 dependant and independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245-257.
12. Compton A (1952): A cytochemical and cytological study of the connective tissue mast cell. Am J Anat 91:301-326.
13. Cross AH, Canella B, Brosnan CF, Raine CS (1990): Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 63:162-170.
14. Cross AH, O'Mara T, Raine CS (1993): Chronological localization of myelin-reactive cells in the lesions of relapsing EAE: Implications for multiple sclerosis. Neurology 43:1028-1033.
15. deKozak Y, Sainte-Laudy J, Benveniste J, Faure J (1981): Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur J Immunol 11:612-617.
16. Dietsch GN, Hinrichs DJ (1989): The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J Immunol 142(5):1476-1481.
17. Dropp J (1976): Mast cells in mammalian brain, I. Distribution. Acta Anat 94:1-21.
18. Edvinsson L, Cervos-Navarro J, Larsson L, Owman C, Ronnberg, A (1977): Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain. Neurology 27:878-883.
19. Galli SJ, Dvorak AM, Dvorak HF (1984): Basophils and mast cells: Morphologic insights into their biology, secretory patterns, and function. Progr Allergy 34:1-141.
20. ERI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 174:103-107.
21. Griffin D, Mendoza QP (1986): Identification of the inflammatory cells present in the central nervous system of normal and mast cell-deficient mice during sindbis virus encephalitis. Cell Immunol 97:454-459.
22. Haisa S, Chang HS, Bewtra AK, Hiratani M, Tarnura N, Bewtra C, Townley RG (1992): Long term cultured mouse mast cells: Ultrastructure, histamine and leukotriene levels. Int Arch Al-lergy Immunol 98:169-177.
23. Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ (1989): Stimulated secretion of endothelial von Willibrand factor is accompanied by rapid distribution of the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 264:7768-7771.
24. Hickey WF, Hsu B, Kimura H (1991): T lymphocyte entry into the central nervous system. J Neurosci Res 28:254-260.
25. Hofman FM, von Hanwehr RI, Dinarelli CA, Mizel SB, Hinton D, Merrilll JE (1986): Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 136:3239-3245.
26. Hofman FM, Hinton D, Johnson K, Merrill JE (1989): Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
27. Ibrahim M (1974): The mast cells of the mammalian central nervous system. I. Morphology, distribution and histochemistry. J Neurol Sci 21:431-478.
28. Kruger PG, Bo L, Myhr KM, Karlsen AE, Taule A, Nyland HI, Mork S (1990): Mast cells and multiple sclerosis: A light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol Scand 81:31-36.
29. Kubes P, Kanwar S (1994): Histamine induces leukocyte rolling in postcapillary venules. A P-selectin mediated event. J Immunol 152:3570-3577.
30. Linthicum DS (1982): Development of acute experimental autoimmune encephalomyelitis in mice: Factors regulating the effector phase of the disease. Immunobiology 162:221-220.
31. Mayadas TN, Johnson RC, Royburn H, Hynes RD, Wagner DD (1993): Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 74:541-554.
32. Naparstek Y, Cohen I, Fuks Z, Vlodavsky I (1984): Activated T lymphocytes produce a matrix-degrading heparin sulphate and endoglycosidase. Nature 310:241-244.
33. Orr E (1989): Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis. Ann NY Acad Sci 540:723-726.
34. Orr E, Stanley N (1989): Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomy-elitis. J Neurochem 53:111-118.
35. Powell H, Braheny S, Myers R, Rodriquez M, Lampert P (1983): Early changes in experimental allergic neuritis. Lab Invest 48:332-338.
36. Prineas JW (1985): The neuropathology of multiple sclerosis. In Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC (eds): "Handbook of Clinical Neurology, Demyelinating Diseases." Amsterdam: Elsevier Science Publishers, pp 213-257.
37. Raine CS (1983): Multiple sclerosis and chronic relapsing EAE: Comparative ultrastructural neuropathology. In Hallpike JF, Adams CWM, Tourtellote WW (eds): "Multiple Sclerosis." Baltimore: Williams and Wilkins, pp 413-478.
38. Raine CS, Scheinberg LC (1988): On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 20:189-201.
39. Raine CS, Lee SC, Scheinberg LC, Duijvestijn AM, Cross AH (1990): Adhesion molecules on endothelial cells in the central nervous system: An emerging area in the neuroimmunology of multiple sclerosis. Clin Immunol Immunopathol 57:173-187.
40. Schwartz LB, Austen KF (1984): Structure and function of the chemical mediators of mast cells. Progr Allergy 34:271-321.
41. Sedgwick J, Brostoff S, Mason D (1987): Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. J Exp Med 165:1058-1075.
42. Simmons RD, Bernard CCA, de Rosbo NK, Carnegie PR (1984): Criteria for an adequate explanation of typical clinical signs of EAE in rodents. Progress in Clinical and Biological Research. 146:23-29.
43. Sobel RA, Mitchell ME, Fondren G (1990): Intracellular adhesion molecule-1 (ICAM-1) in cellular immune interactions in the central nervous system. Am J Pathol 136:1309-1316.
44. + T cell populations that mediate delayed-type hypersensitivity. J Immunol 133:2402-2411.
45. Van Loveren H, Kraeuter-Kops S, Askenase P (1984b): Different mechanisms of release of vasoactive amines by mast cells in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur J Immunol 14:40-47.
46. Walsh L, Trinchieri G, Waldorf H, Whitaker D, Murphy G (1991): Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88:4220-4224.
47. Waxman F, Taguiam J, Whitacre C (1984): Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine. Cell Immunol 85:82-93.
48. Yong T, Linthicum DS (1996): Microvascular leakage in mouse pial venules induced by bradykinin. Brain Injury 10:385-393.
49. Yong T, Bebo BF, Jr, Sapatino BV, Welsh CJ, Orr EL, Linthicum DS (1994): Histamine-induced microvascular leakage in pial venules: Differences between the SJL/J and BALB/c inbred strains of mice. J Neurotrauma 11:161-171.
50. Yong T, Zheng MQ, Linthicum DS (1996): Histamine induces leukocyte rolling in cerebral microcirculation of SJL mice, but not BALB/c mice. Submitted.